KIIDS-TBI vs Oculabs - Health使用状況と統計
A clinical decision support tool that is intended to help guide the management of children with mild traumatic brain injury and intracranial injury.
Disclaimer: This application is meant to be used by medical professionals. As a reminder, please speak to your doctor before making any medical decisions.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
"Introducing Oculabs, a cutting-edge mobile app redefining the management of mild traumatic brain injuries (mTBIs). With Oculabs, healthcare providers can seamlessly assess and monitor patients remotely, empowering both patients and providers in the journey toward recovery.
For providers, Oculabs offers a comprehensive web app interface, streamlining assessments and patient monitoring. Through user-friendly tools and customizable features, providers can accurately diagnose concussions and remotely manage their patients throughout the recovery process.
For patients, the innovation lies in the Oculabs mobile app. Upon enrollment by their provider, patients gain access to a powerful tool that keeps them connected to their healthcare team every step of the way. With support for baseline measurements and injury events, patients can monitor their progress and provide valuable insights to their providers, facilitating a timely return to activity process.
Oculabs is dedicated to providing patients with comprehensive reporting on their recovery progress and assessment data. With detailed insights readily available, patients can make informed decisions and actively participate in their journey toward recovery. Experience the future of concussion management with Oculabs. Download the app today and navigate your recovery journey like never before."
- Apple App ストア
- 無料
- ヘルス & フィットネス
ストアランキング
- -
KIIDS-TBI対Oculabs - Healthランキング比較
と過去28日間の KIIDS-TBI ランキング傾向を比較 Oculabs - Health
ランキング
ご利用可能なデータがありません
KIIDS-TBI 対 Oculabs - Health 国の比較によるランキング
と過去28日間の KIIDS-TBI ランキング傾向を比較 Oculabs - Health
表示できるデータはありません
無料トライアルで任意のサイトと比較する
KIIDS-TBI VS.
Oculabs - Health
12月 31, 2024